Cargando…

Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma

Background: Accumulating evidence suggested that tumor microenvironment and host immune system played important roles in determining the clinical course and outcome of human malignancies. The derived neutrophil to lymphocyte ratio (dNLR) and absolute lymphocyte count (ALC) were demonstrated to act a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiangxiang, Sun, Xiaogang, Zhao, Wenbo, Fang, Xiaosheng, Wang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511611/
https://www.ncbi.nlm.nih.gov/pubmed/31190991
http://dx.doi.org/10.2147/CMAR.S193397
_version_ 1783417597410148352
author Zhou, Xiangxiang
Sun, Xiaogang
Zhao, Wenbo
Fang, Xiaosheng
Wang, Xin
author_facet Zhou, Xiangxiang
Sun, Xiaogang
Zhao, Wenbo
Fang, Xiaosheng
Wang, Xin
author_sort Zhou, Xiangxiang
collection PubMed
description Background: Accumulating evidence suggested that tumor microenvironment and host immune system played important roles in determining the clinical course and outcome of human malignancies. The derived neutrophil to lymphocyte ratio (dNLR) and absolute lymphocyte count (ALC) were demonstrated to act as a prognostic factor in several malignancies. Nevertheless, the prognostic significance of them in extranodal natural killer/T-cell lymphoma (ENKTL) patients has never been explored. Patients and methods: A total of 33 newly diagnosed patients with ENKTL were included in this study. Clinicopathological characteristics were collected and prognostic significance of dNLR and ALC were evaluated. Results: Elevated dNLR and low ALC were both associated with poor survival rates. Patients with dNLR ≥3.6 revealed significantly shorter overall survival (OS) (P=0.001) and progression-free survival (PFS) (P=0.008) than those with dNLR <3.6. Patients with ALC <0.8×10(9)/L had worse OS (P=0.008) and PFS (P<0.001) than those with ALC ≥0.8×10(9)/L. An independent significant association between low ALC and poor clinical outcome in multivariate analysis for OS (HR, 36.023; 95% CI, 2.438–532.243; P=0.009) as well as PFS (HR, 7.698; 95%CI, 1.573–37.679; P=0.012) was identified. Conclusion: In this study, we validated for the first time the prognostic value of dNLR and ALC in ENKTL patients. Elevated dNLR and low ALC were both associated with aggressive tumor process and poor survival.ALC value at diagnosis represented an independent favorable prognostic factor for the clinical outcome of ENKTL patients.
format Online
Article
Text
id pubmed-6511611
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-65116112019-06-12 Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma Zhou, Xiangxiang Sun, Xiaogang Zhao, Wenbo Fang, Xiaosheng Wang, Xin Cancer Manag Res Original Research Background: Accumulating evidence suggested that tumor microenvironment and host immune system played important roles in determining the clinical course and outcome of human malignancies. The derived neutrophil to lymphocyte ratio (dNLR) and absolute lymphocyte count (ALC) were demonstrated to act as a prognostic factor in several malignancies. Nevertheless, the prognostic significance of them in extranodal natural killer/T-cell lymphoma (ENKTL) patients has never been explored. Patients and methods: A total of 33 newly diagnosed patients with ENKTL were included in this study. Clinicopathological characteristics were collected and prognostic significance of dNLR and ALC were evaluated. Results: Elevated dNLR and low ALC were both associated with poor survival rates. Patients with dNLR ≥3.6 revealed significantly shorter overall survival (OS) (P=0.001) and progression-free survival (PFS) (P=0.008) than those with dNLR <3.6. Patients with ALC <0.8×10(9)/L had worse OS (P=0.008) and PFS (P<0.001) than those with ALC ≥0.8×10(9)/L. An independent significant association between low ALC and poor clinical outcome in multivariate analysis for OS (HR, 36.023; 95% CI, 2.438–532.243; P=0.009) as well as PFS (HR, 7.698; 95%CI, 1.573–37.679; P=0.012) was identified. Conclusion: In this study, we validated for the first time the prognostic value of dNLR and ALC in ENKTL patients. Elevated dNLR and low ALC were both associated with aggressive tumor process and poor survival.ALC value at diagnosis represented an independent favorable prognostic factor for the clinical outcome of ENKTL patients. Dove 2019-05-07 /pmc/articles/PMC6511611/ /pubmed/31190991 http://dx.doi.org/10.2147/CMAR.S193397 Text en © 2019 Zhou et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhou, Xiangxiang
Sun, Xiaogang
Zhao, Wenbo
Fang, Xiaosheng
Wang, Xin
Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
title Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
title_full Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
title_fullStr Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
title_full_unstemmed Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
title_short Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
title_sort prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/t-cell lymphoma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511611/
https://www.ncbi.nlm.nih.gov/pubmed/31190991
http://dx.doi.org/10.2147/CMAR.S193397
work_keys_str_mv AT zhouxiangxiang prognosticsignificanceofperipheralbloodabsolutelymphocytecountandderivedneutrophiltolymphocyteratioinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma
AT sunxiaogang prognosticsignificanceofperipheralbloodabsolutelymphocytecountandderivedneutrophiltolymphocyteratioinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma
AT zhaowenbo prognosticsignificanceofperipheralbloodabsolutelymphocytecountandderivedneutrophiltolymphocyteratioinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma
AT fangxiaosheng prognosticsignificanceofperipheralbloodabsolutelymphocytecountandderivedneutrophiltolymphocyteratioinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma
AT wangxin prognosticsignificanceofperipheralbloodabsolutelymphocytecountandderivedneutrophiltolymphocyteratioinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma